Analyst picks & changes

ImmuLogic Pharmaceutical Corp.

(IMUL), Waltham, Mass.

Business: Autoimmune/Inflammation

UBS Securities analyst Tim Wilson lowered his rating to "hold" from "buy" following

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.